DSpace Repository

¿Qué representa cambiar el umbral diagnóstico de la hipertensión arterial? Guías ACC/AHA 2017 y su aplicación en Perú

Show simple item record

dc.contributor.author Hernández-Vásquez, A.A.
dc.contributor.author Rojas-Roque, C.
dc.contributor.author Santero, M.
dc.contributor.author Ruiz-Maza, J.C.
dc.contributor.author Casas-Bendezú, M.
dc.contributor.author Miranda, J.J.
dc.date.accessioned 2019-12-06T21:04:46Z
dc.date.available 2019-12-06T21:04:46Z
dc.date.issued 2019
dc.identifier.uri https://hdl.handle.net/20.500.12866/7618
dc.description.abstract Introduction and Objective: There is little evidence in Latin America about the impact of the ACC/AHA 2017 guideline. Taking as reference the JNC 7 guideline, the objective of our study is to estimate changes in the prevalence of arterial hypertension (HBP) according to socio-demographic characteristics and geographic regions, applying the criteria of the new ACC / AHA guide 2017. Methods: Cross-sectional study of the Demographic and Family Health Survey conducted in Peru in 2017. Standardized weighted hypertension prevalence’s were estimated for the WHO population according to both guidelines, and absolute differences with 95% CI. Results: We included 30,682 people aged 18 years and over, with an average age of 42.3 years, 51.1% women. The standardized prevalence of HBP for 2017 according to JNC 7 was 14.4% (95% CI: 13.8-15.1) and according to ACC / AHA 2017 it was 32.9% (95% CI: 32.0-33.7), so the prevalence increase is 18.5 percentage points, being higher in males than females (24.2 vs 12.9 respectively). In people with obesity and / or who consume tobacco, the increases were higher (24.3 and 24.1 percentage points respectively). In the regions of Tacna, Ica and Metropolitan Lima, the increase, in comparison with the JNC 7 guidelines, overcome the national average (22.4, 20.7 and 20.4, percentage points, respectively). Conclusions: Considering the context of a Latin American country and knowing the epidemiology of hypertension in Peru, the potential adoption of the ACC/AHA 2017 guidelines for the prevention, detection, evaluation, and management of hypertension should be accompanied by an evaluation of the impact at the individual, system and social level. en_US
dc.language.iso spa
dc.publisher SciELO
dc.relation.ispartof urn:issn:0717-6163
dc.rights info:eu-repo/semantics/restrictedAccess
dc.rights.uri https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.subject Cross-sectional studies en_US
dc.subject Epidemiology en_US
dc.subject Hypertension en_US
dc.subject Peru en_US
dc.subject Prevalence en_US
dc.title ¿Qué representa cambiar el umbral diagnóstico de la hipertensión arterial? Guías ACC/AHA 2017 y su aplicación en Perú es_PE
dc.title.alternative Changes in the prevalence of hypertension in Peru using the new guideline of the American college of cardiology en_US
dc.type info:eu-repo/semantics/article
dc.identifier.doi https://doi.org/10.4067/S0034-98872019000500545
dc.subject.ocde https://purl.org/pe-repo/ocde/ford#3.02.00 es_PE
dc.subject.ocde https://purl.org/pe-repo/ocde/ford#3.02.00

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

info:eu-repo/semantics/restrictedAccess Except where otherwise noted, this item's license is described as info:eu-repo/semantics/restrictedAccess

Search DSpace


My Account